Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient.
Eckert
A
A
Schoeffler
A
A
Dalle
S
S
Phan
A
A
Kiakouama
L
L
Thomas
L
L
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*; D000074324:Ipilimumab; D008545:Melanoma / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary*; D012507:Sarcoidosis / Q000139:chemically induced*; D017565:Sarcoidosis, Pulmonary / Q000139:chemically induced; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*
D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D000074324:Ipilimumab